Previous Close | 3.3700 |
Open | 3.2900 |
Bid | 3.0000 x 100 |
Ask | 3.0900 x 100 |
Day's Range | 2.8800 - 3.2900 |
52 Week Range | 1.2800 - 4.2700 |
Volume | |
Avg. Volume | 146,708 |
Market Cap | 189.425M |
Beta (5Y Monthly) | 0.88 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Comparing GALT's Performance Against Analyst Estimates and Exploring Future Prospects
Key Insights Galectin Therapeutics' significant retail investors ownership suggests that the key decisions are...
Key Insights Significant control over Galectin Therapeutics by individual investors implies that the general public has...